Literature DB >> 7895397

Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus.

S C Hsieh1, C Y Tsai, K H Sun, H S Yu, S T Tsai, J C Wang, Y Y Tsai, S H Han, C L Yu.   

Abstract

OBJECTIVE: Interleukin 8 (IL-8) acts as a potent chemotactic cytokine and also as an autocrine factor for polymorphonuclear neutrophils (PMN), thus amplifying the acute inflammatory reaction. We undertook to study the IL-8 producing capacity of PMN in patients with systemic lupus erythematosus (SLE).
METHODS: PMN from twelve patients with active SLE, from fifteen patients with inactive disease and from sixteen healthy individuals were incubated for 24 hours in medium alone, or in medium with lipopolysaccharide (LPS) or TNF-alpha. The IL-8 concentration in the culture supernatants was measured by an enzyme linked immunosorbent assay.
RESULTS: We found that the spontaneous and LPS-stimulated, but not TNF-alpha-stimulated, production of IL-8 by the PMN of active SLE patients were significantly lower than that of healthy individuals. The impaired IL-8 production by SLE-PMN was linked to disease activity but not to the administration of steroid, because incubation of normal PMN or inactive SLE-PMN with prednisolone (1 microgram/ml and 5 micrograms/ml) for 24 hours did not affect IL-8 production. In addition, IL-8 production increased in three active SLE patients after effective treatment with immunosuppressants but not in two cases of ineffective treatment, in the follow-up study.
CONCLUSION: These results suggest that decreased IL-8 production is one of the defects of PMN in patients with active SLE, which might predispose SLE patients to infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895397

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

1.  C1qRP (CD93) expression on peripheral blood monocytes in patients with systemic lupus erythematosus.

Authors:  Frank Moosig; Erika Fähndrich; Anja Knorr-Spahr; Sebastian Böttcher; Matthias Ritgen; Rainald Zeuner; Michael Kneba; Johann O Schröder
Journal:  Rheumatol Int       Date:  2006-05-04       Impact factor: 2.631

2.  Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

Authors:  A Csiszár; G Nagy; P Gergely; T Pozsonyi; E Pócsik
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus.

Authors:  S-C Hsieh; H-S Yu; W-W Lin; K-H Sun; C-Y Tsai; D-F Huang; Y-Y Tsai; C-L Yu
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites.

Authors:  Herve Y Sroussi; Yu Lu; Qin L Zhang; Dana Villines; Phillip T Marucha
Journal:  Free Radic Res       Date:  2010-04

Review 5.  Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation.

Authors:  Tsai-Hung Wu; Song-Chou Hsieh; Tsu-Hao Li; Cheng-Hsun Lu; Hsien-Tzung Liao; Chieh-Yu Shen; Ko-Jen Li; Cheng-Han Wu; Yu-Min Kuo; Chang-Youh Tsai; Chia-Li Yu
Journal:  Biomedicines       Date:  2022-03-25

6.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

7.  Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile.

Authors:  Sana Al-Mutairi; Adel Al-Awadhi; Raj Raghupathy; Hanaa Al-Khawari; Prio Sada; Adeebah Al-Herz; Parvez Rawoot
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 3.580

Review 8.  Cutaneous mucormycosis in a patient with lupus nephritis: A case report and review of literature.

Authors:  Wenrong Cheng; Guoqin Wang; Min Yang; Lijun Sun; Hongrui Dong; Yipu Chen; Hong Cheng
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

9.  Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.

Authors:  Chung-Yuan Hsu; Chi-Hua Ko; Jiun-Ling Wang; Tsai-Ching Hsu; Chun-Yu Lin
Journal:  Arthritis Res Ther       Date:  2019-10-12       Impact factor: 5.156

Review 10.  Infection and Lupus: Which Causes Which?

Authors:  Sarah Doaty; Harsh Agrawal; Erin Bauer; Daniel E Furst
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.